Stay updated on MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The revision label changed from v3.5.3 to v3.5.4, indicating a small update to the study record. This appears to be a metadata or documentation update rather than a substantive change to the study data or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-15T03:07:20.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.5.2 to v3.5.3. This represents a minor update to the page template and does not change the study details or data presented.
    Difference
    0.1%
    Check dated 2026-04-30T17:32:21.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the page footer as part of a site update.
    Difference
    0.1%
    Check dated 2026-04-16T11:20:19.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Page revision history updated: v3.4.3 was removed and v3.5.0 was added.
    Difference
    0.1%
    Check dated 2026-03-18T20:31:04.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:36:19.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior notice about government funding and operating status (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:28:20.000Z thumbnail image

Stay in the know with updates to MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.